Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
135 participants
OBSERVATIONAL
2019-06-01
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluid Management Surgical Patients in Intensive Care Unit.
NCT03455296
Lactate Level and Gastrointestinal Bleeding
NCT04104425
Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2: a Prospective Randomized Superiority Study (The LACTEL Study)
NCT05032521
Feasibility of Lactate Level Evaluation in Prehospital Care in Trauma
NCT03115970
Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)
NCT00270673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This trial included traumatic, medical and surgical patients requiring ICU stay for a predictive period \> to 24 hours.
Blood lactates were evaluated as a prognostic parameter in predicting ICU mortality and compared to classic prognostic scores such as: SOFA score, IGS II and APACHE II.
The primary end point was ICU mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors
Patients discharged alive from intensive care unit
Blood lactate level
Blood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48
non survivors
Patients who succumbed during their ICU stay
Blood lactate level
Blood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood lactate level
Blood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
Professor head of ICU department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mongi Slim University Hospital
La Marsa, Tunis Governorate, Tunisia
Mongi Slim Hospital
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lactates ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.